ESR1 and breast cancer: Younger women are more prone to getting a more aggressive form of breast cancer, like triple-negative breast cancer (estrogen receptor (ER)/progesterone receptor (PR) negative and human epidermal growth factor receptor 2 (HER2) negative for amplification).